TD Waterhouse Canada Inc. EPRX β€” EUPRAXIA PHARMACEUTICALS INC

Ownership history in TD Waterhouse Canada Inc.  Β·  7 quarters on record

AI Ownership Summary

TD Waterhouse Canada Inc. reported EUPRAXIA PHARMACEUTICALS INC (EPRX) in 7 quarterly 13F filings from 2024 Q3 through 2026 Q2. The latest visible filing shows EPRX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this EPRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was TD Waterhouse Canada Inc.'s position in EUPRAXIA PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

EPRX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

EPRX stock page TD Waterhouse Canada Inc. fund profile TD Waterhouse Canada Inc. full holdings
How TD Waterhouse Canada Inc. held EPRX β€” position size vs. price
% of Fund (quarterly)    EPRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 7 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED β€” β€” β€” 79,607 -2,118 -2.6% 0.00% $535K 2026-07-27 $6.17
2026 Q1 ADDED β€” β€” β€” 81,725 +72,125 +751.3% 0.00% $590K 2026-05-12 $7.61
2025 Q4 UNCHANGED β€” β€” β€” 9,600 β€” 0% 0.00% $72K 2026-01-27 $8.99
2025 Q3 UNCHANGED β€” β€” β€” 9,600 β€” 0% 0.00% $56K 2025-11-03 $6.09
2025 Q2 REDUCED 90.9% -0.2% βœ… 9,600 -95,386 -90.9% 0.00% $56K 2025-08-11 $5.32
2025 Q1 ADDED β€” β€” β€” 104,986 +103,486 +6899.1% 0.00% $343K 2025-05-09 $3.80
2024 Q3 INITIATED β€” β€” β€” 1,500 β€” β€” 0.00% $4K 2024-11-12 $2.90

🏒 Other funds also holding EPRX

As of 2026 Q2 β€” sorted by position size

China Universal Asset Management Co., Ltd. 3Y 0.0% TCI Wealth Advisors, Inc. 3Y 7Y 0.0%

FAQ About TD Waterhouse Canada Inc. and EPRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has TD Waterhouse Canada Inc. reported owning EPRX?

TD Waterhouse Canada Inc. reported EPRX across 7 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported EPRX position in TD Waterhouse Canada Inc.'s portfolio?

The largest reported portfolio weight for EPRX was 0.00% in 2025 Q1.

What is the latest reported EPRX position on this page?

The most recent filing on this page is 2026 Q2, when TD Waterhouse Canada Inc. reported 79,607 shares, equal to 0.00% of portfolio, with an estimated market value of $535K.

What does the chart on this EPRX ownership page compare?

The chart compares TD Waterhouse Canada Inc.'s quarterly EPRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did TD Waterhouse Canada Inc. time their EPRX position?

Based on 13F filing dates vs. subsequent EPRX price moves, TD Waterhouse Canada Inc. correctly timed 2 out of 4 reported position changes (50%). The annualised alpha on EPRX relative to SPY over the holding period was +35.8%.

← Back to TD Waterhouse Canada Inc. Holdings